Related Experiment Video

Updated: Apr 19, 2026

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

6.8K

Cardiac troponin assays in the management of heart failure

Matthew Torre1, Petr Jarolim2

  • 1Harvard Medical School, Boston, MA, USA.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 30, 2014
PubMed

Insights

Cardiac troponin testing is crucial for diagnosing heart attacks and predicting heart failure. New high-sensitivity assays reveal cardiac troponin levels correlate with heart failure severity and may guide treatment.

Area of Science:

  • Cardiology
  • Biomarker Research
  • Heart Failure Management

Background:

  • Cardiac troponins (I and T) are key biomarkers for cardiac injury and acute myocardial infarction diagnosis.
  • Elevated cardiac troponin levels post-myocardial infarction predict adverse events, including heart failure.
  • Chronic troponin elevations correlate with heart failure severity, especially with high-sensitivity assays.

Purpose of the Study:

  • To review the prognostic utility of cardiac troponin measurements in acute and chronic heart failure.
  • To explore the relationship between cardiac troponin levels and heart failure severity.
  • To summarize research on serial troponin monitoring for guiding heart failure therapy.

Main Methods:

  • Literature review of studies on cardiac troponin testing in heart failure patients.
  • Analysis of prognostic and correlative data linking troponin levels to heart failure outcomes and severity.
  • Summary of current research and debates on therapeutic monitoring using troponins.

Main Results:

  • Cardiac troponin testing is essential for acute myocardial infarction diagnosis.
  • Troponin levels predict future adverse events and correlate with heart failure severity, particularly with high-sensitivity assays.
  • High-sensitivity troponin assays enhance the prognostic and correlative power of these biomarkers in heart failure.

Conclusions:

  • Cardiac troponin testing has significant prognostic implications for patients with heart failure.
  • Measuring troponin levels can inform risk stratification and potentially guide therapeutic interventions.
  • Further research is needed to establish serial troponin monitoring as a standard tool in heart failure management.

Keywords:
AssayCardiac troponinHeart failureHigh sensitivityManagementMonitoring

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

17.2K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.9K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
483
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
331
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
489
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
785
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K